Virtus Investment Advisers, Inc. Replimune Group, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 9,513 shares of REPL stock, worth $85,141. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,513
Previous 13,434
29.19%
Holding current value
$85,141
Previous $130,000
32.31%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
196Shares Held
77.5MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$98.9 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$96.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$42.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$41.7 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$35 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $441M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...